Interferon-alpha gene therapy

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameInterferon-alpha gene therapy
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionInterferon alpha stimulants
TargetsInterferon alpha
Therapy Area/IndicationsCarcinoma, HepatocellularInfluenza, HumanRespiratory Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwanAustraliaMainland China
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaPending
Originator CompaniesJohns Hopkins UniversityValentisUniversity Of Kentucky +[6] 
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAinos IncFudan University
Active IndicationsN/A
Inactive IndicationsCarcinoma, HepatocellularInfluenza, HumanRespiratory Tract Infections

Other Information

ATC CodeN/A
Related LinksN/A